BioWorld MedTech

May 27, 2010

Compelling in registry results clinch clinical case for TAVI

PARIS – Transcatheter aortic valve implants (TAVI) have experienced a rapid take-up in Europe since the procedure was introduced in 2007. {Medical Device Daily} Read More

Docs weigh in on outlook for innovation & medical practice

Shuren takes aim at change of culture for Center for Devices

Survey: lawsuit fears hinder adoption of new med-tech

Report from Europe: Volcano wins CE mark for vascular imaging catheter

MDD's food for med tech thought

Deals roundup: Covidien to shed Specialty Chemicals for $280M in cash

People in the News

Patent watch: Applied Spine gets two patents expanding Stabilimax portfolio

Med-Tech's Next Great Opportunity: Obesity

Product Briefs

MDD's Ortho Extra

Today's news in brief

BioWorld

BioWorld briefs for May 21, 2026.

Acid alpha-glucosidase molecular structure isolated on black

‘Detargeted’ targeted gene therapy improves activity in Pompe

BioWorld

A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...

News in brief

BioWorld Asia

BioWorld Asia briefs for May 19, 2026

WHO declares Ebola outbreak a public health emergency of international concern

BioWorld

The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...

Nxera Pharma prepares and tests new GPR17 antagonists

BioWorld Science

Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...